Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02548962
Title Study of Ibrutinib in Combination With Pomalidomide and Dexamethasone in Subjects With Relapsed/Refractory Multiple Myeloma
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Pharmacyclics
Indications
Therapies
Age Groups: adult
Covered Countries USA | GRC | ESP | DEU | CZE | AUS

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
Medical University of South Carolina Charleston South Carolina 29425 United States Details
Virginia Commonwealth University Richmond Virginia 23298 United States Details
Concord Repatriation General Hospital Concord New South Wales 2139 Australia Details
Princess Alexandra Hospital Woolloongabba Queensland 4102 Australia Details
Fakultni nemocnice Brno Brno 625 00 Czechia Details
Fakultni nemocnice Ostrava Ostrava 708 52 Czechia Details
Vseobecna fakultni nemocnice v Praze Praha 128 08 Czechia Details
Universitätsklinikum Carl Gustav Carus Dresden 01307 Germany Details
'Alexandra' General Hospital of Athens Athens Attiki 11528 Greece Details
Clinica Universidad de Navarra Pamplona Navarra 31008 Spain Details
Hospital de La Santa Creu i Sant Pau Barcelona 08025 Spain Details
Hospital Universitario de Salamanca Salamanca 37007 Spain Details
Hospital Universitario Doctor Peset Valencia 46017 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field